Monitor the final prospectus supplement for the actual offering size, price and discount to assess dilution relative to the $2M market cap. The company's Nasdaq listing status remains precarious given the cumulative reverse split ratio and the offering price being below the $1.00 minimum bid price.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 19 $0.0350entry
- T+1 · 2d ago −23.14%α −19.50% · $0.0269
- T+5 · in 5d Pending
- T+20 · in 26d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
NewGenIvf Group filed a preliminary prospectus supplement for a firm-commitment underwritten offering of Class A Ordinary Shares and pre-funded warrants, with all key terms (share count, price, discount) left as placeholders. The filing also discloses a Limited Waiver and Repurchase Agreement with noteholder JAK Opportunities VI LLC, requiring a $625,000 repurchase of $584,112 in principal from offering proceeds. The company has a $2M market cap, is under Nasdaq delisting risk, and has executed ten reverse stock splits since February 2025 with a cumulative ratio of approximately 17,280,000-to-1.
Key Financial Metrics
Key Facts
- Firm-commitment underwritten offering of Class A Ordinary Shares and pre-funded warrants; all terms (size, price, discount) are placeholder values.
- 2,993,502 Class A and 9,136 Class B shares outstanding as of November 18, 2026.
- Last reported sale price on November 18, 2026 was US$0.17 per share.
- Underwriter is Aegis Capital Corp.; underwriting discount is 9.0% of gross proceeds.
- Mandatory repurchase of $584,112 principal of the JAK Exchange Note for $625,000 from offering proceeds.
- Company has been under Nasdaq delisting notice since November 2024; ten reverse stock splits with cumulative ratio of ~17,280,000-to-1 since February 2025.
- Another 1-for-100 reverse stock split approved with tentative effective date of December 1, 2026.
- Revenue for six months ended June 30, 2026 was $1,924,881, down from $2,019,628 in the prior-year period.
- Net loss for six months ended June 30, 2026 was $(8,079,392) vs net income of $698,032 in the prior-year period.
- Market cap is $2M; normal daily move is 34.7%.
Financial Impact
Offering size, price and discount are undisclosed; $625,000 of gross proceeds committed to repurchase $584,112 of the JAK Exchange Note.
Risk Factors
- All offering terms are placeholders; the final terms could be highly dilutive given the $2M market cap.
- Nasdaq delisting risk is elevated: the offering price is below $1.00, and the cumulative reverse split ratio of 17,280,000-to-1 eliminates the ordinary bid-price compliance period.
- Revenue declined 4.7% YoY and the company swung to a $8.1M net loss for the six months ended June 30, 2026.
- document contains text addressed to automated readers
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001213900-26-122016 |
| Document: 0001213900-26-122016-index-headers.html | 0001213900-26-122016 |
| Document: 0001213900-26-122016-index.html | 0001213900-26-122016 |
| Document: 0001213900-26-122016.txt | 0001213900-26-122016 |
Track record
27 reports on NIVF
10 of 12 bullish or bearish reports moved the stock their way by T+20. Best: +99.57% at T+60 after the Aug 20, 2026 report. 13 of 13 went positive at some point.
Filters
- Nov 20, 20261d ago 424B5 Bearish 7/10 Entry $0.0318 Now $0.0270 +15.09% settles Dec 21
- Nov 19, 20262d ago 424B5 Bearish 6/10 Viewing Entry $0.0350 Now $0.0270 +22.86% settles Dec 18
- Nov 17, 20264d ago 6-K Neutral 2/10 Entry $0.1728 Now $0.0270 −84.37% settles Dec 16
- Nov 16, 20265d ago 6-K Neutral 3/10 Entry $0.2050 Now $0.0270 −86.83% settles Dec 15
- Nov 13, 20269d ago EFFECT Bearish 5/10 Entry $0.2312 Now $0.0270 +88.32% settles Dec 14
- Oct 21, 20264w ago 6-K Neutral 4/10 Entry $0.1884 Now $0.0270 −85.67% due Nov 18
- Oct 7, 20266w ago 6-K Bearish 7/10 Entry $0.0811 to $0.0152 Now $0.0270 +66.71% ▲ +81.23% +75.94% vs SPY
- Oct 7, 20266w ago 6-K Neutral 3/10 Entry $0.1060 to $0.0216 Now $0.0270 −74.53% ▼ −79.58% −78.24% vs SPY
- Oct 6, 20266w ago SC 13D/A Neutral 3/10 Entry $0.0987 to $0.0266 Now $0.0270 −72.64% ▼ −73.09% −69.91% vs SPY
- Oct 5, 20266w ago 6-K Bearish 6/10 Entry $0.1100 to $0.0306 Now $0.0270 +75.45% ▲ +72.16% +69.70% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers